Catalyst Wire Dossier Catalyst Wire Dossier

BCMA CAR-T therapy

BCMA-targeted chimeric antigen receptor T-cell therapy
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BCMA CAR-T therapy, covering 2025-08-03 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma [Phase 2]

See pricing